公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2021 | High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia | LIN, CHING-HUNG ; RUBY YUN-JU HUANG ; TZU-PIN LU ; KUAN-TING KUO ; Lo, Ko-Yun; Chen, Ching-Hsuan; I-CHUN CHEN ; YEN-SHEN LU ; ERIC YAO-YU CHUANG ; Thiery, Jean Paul; CHIUN-SHENG HUANG ; ANN-LII CHENG | NPJ breast cancer | 4 | 4 | |
2015 | High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country | CHING-HUNG LIN ; Shen C.-Y.; JIH-HSIANG LEE ; CHIUN-SHENG HUANG ; CHIH-HSIN YANG ; WEN-HUNG KUO ; DWANG-YING CHANG ; Hsiung C.-N.; KUAN-TING KUO ; WEI-WU CHEN ; I-CHUN CHEN ; Wu P.-F.; SUNG-HSIN KUO ; Chen C.-J.; YEN-SHEN LU ; ANN-LII CHENG | PLoS ONE | 10 | 6 | |
2015 | High serum transforming growth factor-β1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib | Lin T.-H.; YU-YUN SHAO ; Chan S.-Y.; Huang C.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG | Clinical Cancer Research | 78 | 78 | |
1997 | High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy [2] | KUN-HUEI YEH ; ANN-LII CHENG | British Journal of Cancer | 124 | 97 | |
2003 | High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma | KUN-HUEI YEH ; YEN-SHEN LU ; Hsiao C.-H.; ANN-LII CHENG | Anticancer Research | 3 | 3 | |
1997 | High-dose tamoxifen reverses drug resistance to cisplatin and etoposide in a patient with advanced large cell carcinoma of lung | KUN-HUEI YEH ; ANN-LII CHENG | Anticancer Research | 14 | 11 | |
1998 | High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers | KUN-HUEI YEH ; Lin M.-T.; Lin D.-T.; JIH-LUH TANG ; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG ; Yu S.-C.; KING-JEN CHANG ; YAO-CHANG CHEN | Breast Cancer Research and Treatment | 2 | 2 | |
2002 | High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection | JIN-TUNG LIANG ; KUO-CHIN HUANG ; HONG-SHIEE LAI ; PO-HUANG LEE ; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG ; CHIH-HUNG HSU ; KUN-HUEI YEH ; Wang S.-M.; Tang C.; KING-JEN CHANG | International Journal of Cancer | 109 | 98 | |
2008 | Histone deacetylase inhibitors in cancer therapy | Sargeant, Aaron M.; Kulp, Samuel K.; YEN-SHEN LU ; ANN-LII CHENG ; Chen, Ching Shih | Cancer Epigenetics | 0 | | |
2013 | Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma | LI-CHUN LU ; YU-YUN SHAO ; Kuo R.N.C.; ZHONG-ZHE LIN ; Yeh Y.-C.; Shau W.-Y.; CHIH-HUNG HSU ; ANN-LII CHENG ; Lai M.-S. | Cancer | 11 | 11 | |
1999 | Hypermethylation of the p16 gene in sporadic T3NOMO stage colorectal cancers: Association with DNA replication error and shorter survival | JIN-TUNG LIANG ; KING-JEN CHANG ; Chen J.-C.; Lee C.-C.; Cheng Y.-M.; Hsu H.-C.; MING-SHIANG WU ; Wang S.-M.; Lin J.-T.; ANN-LII CHENG | Oncology | 78 | 70 | |
2019 | Hypofractionated particle beam therapy for hepatocellular carcinoma-a brief review of clinical effectiveness | CHE-YU HSU ; CHUN-WEI WANG ; ANN-LII CHENG ; SUNG-HSIN KUO | World Journal of Gastrointestinal Oncology | 7 | 5 | |
2022 | ICOS-Positive Regulatory T Cells in Hepatocellular Carcinoma: The Perspective from Digital Pathology Analysis | LI-CHUN LU ; Deantonio, Cecilia; Palu, Cintia C; Lee, Yi-Hsuan; Mitchell, Laura S; Cowan, Marianne; Corser, Matthew; Sherry, Lorcan; ANN-LII CHENG ; Quaratino, Sonia; YU-YUN SHAO ; Sainson, Richard C A; CHIH-HUNG HSU | Oncology (Switzerland) | 0 | 0 | |
2005 | Identification and characterization of a novel gene Saf transcribed from the opposite strand of Fas | Yan M.-D.; Hong C.-C.; Lai G.-M.; ANN-LII CHENG ; Lin Y.-W.; Chuang S.-E. | Human Molecular Genetics | 84 | 80 | |
2018 | Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancer | BANG-BIN CHEN ; YEN-SHEN LU ; CHIH-WEI YU ; CHING-HUNG LIN ; WEI-WU CHEN ; Wei S.-Y.; ANN-LII CHENG ; TIFFANY TING-FANG SHIH | European Radiology | 9 | 9 | |
2020 | IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation | Hack S.P.; Spahn J.; Chen M.; ANN-LII CHENG ; Kaseb A.; Kudo M.; Lee H.C.; Yopp A.; Chow P.; Qin S. | Future Oncology | 120 | 105 | |
2023 | IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study | Kudo, Masatoshi; Finn, Richard S; Galle, Peter R; Zhu, Andrew X; Ducreux, Michel; ANN-LII CHENG ; Ikeda, Masafumi; Tsuchiya, Kaoru; Aoki, Ken-Ichi; Jia, Jing; Lencioni, Riccardo | Liver cancer | 6 | 4 | |
2022 | Immune checkpoint inhibitors for hepatocellular carcinoma - A game changer in treatment landscape | TSUNG-HAO LIU ; YING-CHUN SHEN ; ANN-LII CHENG | Journal of the Formosan Medical Association = Taiwan yi zhi | 3 | 2 | |
2018 | Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy | Lin Y.-Y.; CHING-TING TAN ; Chen C.-W.; DA-LIANG OU ; ANN-LII CHENG ; CHIUN HSU | Seminars in Liver Disease | 61 | 53 | |
2011 | Impact of baseline hepatitis B viral DNA levels on survival of patients with advanced hepatocellular carcinoma | YU-YUN SHAO ; PEI-JER CHEN ; ZHONG-ZHE LIN ; Huang C.-C.; Ding Y.-H.; Lee Y.-H.; CHIH-HUNG HSU ; ANN-LII CHENG | Anticancer Research | 12 | | |